The London Health Manager for China's elite
Privileged access to London's world-class clinicians, verified medications, and offshore biological custody with the world's most prestigious medical district.
H+ Vision
Harley+ aims to become the world’s first Family Health Office for China and Hong Kong’s elite — a London-anchored platform that gives affluent families guaranteed access to Harley Street’s world-class specialists, certified-safe medications, and offshore biological freedom.
Exclusive Rights
H+ is the world-famous Harley Street Health District's (HSHD) exclusive partner for China and Hong Kong with a 3-year agreement with the Howard De Walden Estate.
Bridge Excellence
H+ connects China's rich with HSHD's world-class medical excellence and specialists with personalised and curated care and certified-safe drug access and treatments.
Biological Capital Custodian
Comprehensive governance of genomics, fertility assets, health data – all ring-fenced for life in the HSHD.
Scalable Model
Structured Shanghai–London service model ensures rapid case progression, 24/7 bilingual navigation, and scalable delivery even as client volume grows.
What is London's Harley Street Health District?
The world's only 150-year-old medical district, globally trusted for elite diagnostics and specialist care. Unmatched in heritage, clinical density and medical expertise.
32 Hospitals
250 Outpatient Clinics
4,500 Medical Businesses
1,500 Practitioners
3,000 Support Staff
The district offers unparalleled access to world-class consultants and surgeons.
What is the Howard De Walden Estate?
The De Walden family's historic 92-acre Marylebone estate with 800 property interests in prime central London—one of the most prestigious landholdings in the UK. Howard de Walden's grandson sits on the Harley+ board as a non-executive director.
Historical note: The Family and its history. The Family is listed in the Sunday Times Rich list 2024 as the 47th richest family in the UK. In 1711 The Duke of Newcastle bought a village near London for £17,000. Today that village is known as the Howard de Walden estate with a value of c.£6 billion.
Howard De Walden Grandson James Buchan (centre), HDW Estate CEO Mark Kildea and James Piesse CEO H+
Major Hospitals in the HSHD
- Cleveland Clinic London
- Mayo Clinic London
- Cedars-Sinai London (2026)
- The London Clinic
- The Portland Hospital
- King Edward VII's Hospital
- The Harley Street Clinic
- The Princess Grace Hospital
- Moorfields Private Eye Hospital
- Royal Brompton & Harefield Hospitals
- Royal Marsden Private Care
3
The Market Opportunity:
H+ will target the HNW "Silver" & initially its "She" Economies.
The "She" Economy:
Professional, unmarried Chinese women aged 30-50 are the fastest-growing demographic for luxury consumption. They are legally barred from egg freezing in China. Chinese women at all social levels control and direct family expenditure.
The booming "Silver" Economy:
China's ageing elite fears cancer and frailty. China Daily predicts this market will rise to 30 Trillion RMB (£3.3 Trillion) by 2035. The epochal shift is toward "Health Consumption" (preventative, anti-aging, lifestyle), which now accounts for 41% of all elderly spending.
China 2024 – the world's 2nd largest market for HNWIs
2.5m
HNWIs (assets >$1.5m)
472k
HNWIs (>$5-10m)
516
Billionaires (China/HK)
Why London?
£15bn
London property investment
(past 10 years)
175k
Chinese students currently in UK
1.1m
Annual visitors from China/HK
London = unquestioned global trust hub for Chinese HNWs
4
A Structural Trust Deficit in China’s Premium Healthcare Market
Accessing specialists in China
A Chinese patient needs a high-level guanxi (network), insider information, ‘Yellow Bulls’ (professional queue jumpers) and money to access the best of best at China's hospitals. Access is otherwise impossible in an overloaded and opaque public system.
Legally restricted practices
Simple quality of life treatments for conditions that are 'taboo' such as Menopause or Erectile Dysfunction treated as 'psychological', forcing sufferers into dubious unlicensed practitioners and medicines.
Drug and device issues
NMPA approval can mean up to a 4-5 year delay for Western drugs. Most public hospitals offer generic copies of modern drugs only.
The Supply Chain Crisis
Widespread distrust of domestic longevity drugs and health supplements due to counterfeits and an unregulated grey market.
China's Regulatory & Biological Constraints
H+ will arbitrage the gaps in the Chinese healthcare and Longevity system with world-class care and drugs
6
Solution:
The Private Health Bank
Harley+ transcends medical tourism or concierge services. We function as a comprehensive Biological Asset & Health Manager.
A bi-city operating model that scales: London clinical oversight paired with Shanghai 24/7 client management.
01
24/7 Access to finest Practitioners
Guaranteed senior HSHD consultants with curated 24/7 navigation and strategic oversight in Chinese. In-house Doctors in Shanghai and London enable consistent, high-quality delivery as client volume grows.
02
Dedicated 24/7 Concierge
Modern premises in China and London with Chinese-speaking staff who will handle consultation, translation, referral, travel and visa, and post-operative care.
03
Sovereignty
Legal access to treatments restricted in China, ensuring medical freedom
04
Provenance
Verified "clean" drug and supplement supply chain sourced exclusively from Royal Warrant pharmacies in HSHD
05
Data Vault
GDPR-compliant complete digitisation of Chinese/English medical history with a WES/WGS Genomic vault
06
Biological Custody
Egg and stem-cell banking in HFEA-licensed UK facilities with international usage rights
The Moat
Our Unfair Advantage
Five Pillars of Competitive Advantage
1
Exclusive HSHD Rights
Sole China rights to "Harley Street Health District" through Howard De Walden Estate board-level 3-year agreement with a De Walden family member on our board and top-end premises for 2 years provided by the Estate.
2
160-Year Density
Over 3,500 specialists concentrated in 92 acres—the highest elite medical expertise globally in one of the world's greatest cities with proximity to Oxford, Cambridge and the Knowledge Quarter.
3
Operational moat:
A dual-hub model that reduces wait times, absorbs high-touch HNW demand, and unlocks scalable service delivery.
4
Regulatory Arbitrage
UK legality enables egg freezing, bio-identical hormones, off-label longevity drugs, and WES/WGS genomics.
5
HK and London Genomic Loophole
If coming to London is not an option, Hong Kong sampling by-passes PRC export restrictions – the only legal genomic exit route for Chinese citizens
There are few competitors in the world that can or do offer these services to Chinese HNWIs
9
The Product Suite
H+ Circle of Trust
Four-Tier Service Architecture
Privileged Clinical Access
- Direct access to top Harley Street specialists
- Senior consultant oversight (not junior doctors)
- Acceleration of appointments (days, not months)
- Structured SOPs and bilingual case management reduce clinical bottlenecks and allow high-volume oversight.
- Trusted second opinions and treatment planning
- Priority referrals across HSHD’s 3,500-establishment network
Exclusive Longevity & Specialist Programmes
Deep-dive, high-margin medical programmes that convert privileged access into long-term outcomes.
- Executive Reset / Longevity Week
- Menopause & Midlife programmes
- Fertility & Egg-Freezing orchestration
- Oncology / Rare Disease / Paediatric MDT case projects
- Tribunal second-opinion panels
Biological Capital Custody
Protecting and governing the data, genomics, and fertility assets that inform elite medical decisions.
- HSHD data custody
- Genomic vault: WES/WGS, variant lists, reinterpretation
- Fertility and biobank administration with global usage rights
- Cross-border compliance (HK genomic exit route)
- Complete digitisation of Chinese/English medical history
- Integrated lifetime record for risk modelling & prevention
Verified London Clinical Supply Chain
Guaranteed provenance and safe access to UK-regulated medications and longevity supplements. As membership grows, pharmacy and supplement supply chain becomes a recurring, zero-marginal-cost revenue engine.
- Verified “clean” drugs dispensed only through Royal Warrant pharmacies
- Safe supply of HRT/TRT, metabolic, and longevity medications
- UK prescription oversight with precise dosing and monitoring
- Premium supplement stack sourced from audited British suppliers
- Secure logistics chain from Harley Street to China/HK
- Eliminates China’s counterfeit risk and guarantees purity, origin, traceability
11
Founders / Legacy Membership
Top-tier offering for 20–30 ultra-high-net-worth families
£25k
Annual Fee
Comprehensive Benefits
- Full genomic baseline (WES/WGS) with professional interpretation
- Complete digitisation of historical medical records in Chinese and English
- Unlimited light concierge with 24/7 WeChat support
- 20 hours deep case management annually
- Annual Biological Capital Review with senior consultants
- Priority access to top Harley Street specialists
- Integrated long-term prevention and genomics strategy
12
Specialised Clinical Programmes
Menopause & Midlife
£8–12K
Specialist consultation, DEXA, metabolic & breast risk assessment, genomic module (BRCA, thrombosis, pharmacogenomics), comprehensive written plan with Vault access
Fertility & Egg-Freezing
£4–7K management + £5–10K clinic
Pre-workup coordination in China, retrieval in UK/EU, genomic carrier screening options, 1–2 years storage included, UK biobanking with global usage rights
Second Opinion Programme
£5–20K
Medical record translation, elite Harley Street or NHS academic consultants, optional genomics integration, trip planning, full written recommendations
Complex Case Projects
Sophisticated medical advocacy for oncology, rare disease, paediatrics, and neurology cases requiring multidisciplinary coordination.
1
Tier 1: £5–7K
Standard complexity cases with consultant coordination and family advocacy
2
Tier 2: £10–15K
Moderate complexity with MDT coordination and diagnostic planning
3
Tier 3: £15–25K
High complexity including tumour sequencing, exome analysis, and international care coordination
Subscription Services
Harley+ Vault
£750–1,500 annually
- Secure storage of all scans, reports, and consultant notes
- Genomic data custody (VCF/BAM/variant lists)
- Chinese and English summaries
- Reinterpretation every 3–5 years
- Custody and convenience focus without concierge services
Biobank / Egg Storage Administration
£600–800 annually
- Consent renewals and compliance management
- Integration of fertility data into the Vault
- London-based reporting and coordination
- Regulatory liaison for international clients
Risk & Strategic Hedging
Harley+ is structured as a UK Asset Holding company with subsidiaries in Hong Kong and China with a global client base, minimising geopolitical exposure.
Key Risks
- China regulatory and geo-political volatility
- Market concentration risk (China as core market)
- Operational scale risk (dual-country medical delivery)
- Medication provenance & supply chain risk
- Travel disruption / cross-border healthcare fluctuation
Strategic Hedges
- 65m+ Chinese expats globally provide stable, diversified demand
- Proven inbound worldwide demand into HSHD from non-Chinese UHNW clients (Africa, India, SE Asia)
- Dual-hub (Shanghai–London) model is modular and replicable in Tier 2 Chinese cities
- Verified UK medication supply chain via Royal Warrant pharmacies
- Platform engine (Vault, Biobank, Medication) remains revenue-stable even without travel. A "Borderless" digital platform
Asset Sovereignty (UK Domicile)
- All IP, Genomics, and Bio-assets held in London.
- UK Legal Framework protects client privacy and data.
Regulatory "Light" Model
- H+ operates as a "Health Office" (Logistics/Data), not a Hospital.
- Minimal exposure to Chinese clinical regulations.
- Supply chain relies on cross-border e-commerce channels.
16
The Future — A Global Private Health Bank
Focused today on China's elite families, engineered for global scalability tomorrow.
Geographic Optionality
- Tier 2 China cities (Chengdu, Hangzhou, Wuhan)
- Emerging wealth markets (Africa, India, Indonesia)
Strategic Innovation
- Health insurance for 150k+ Chinese students in UK
Platform Scalability
- Platform engine allows scalable "asset-light" geographic growth
- Long-term evolution into a global Private Health Bank offering biological capital protection
- 24/7 dual-hub model replicable across time zones
The Model Advantage
- Applies wherever high wealth meets low medical trust
A unique team of medical and China expertise
There are very few people who have had the depth of experience and success in China in sales and marketing as James Piesse. Mr Piesse is a China veteran since early 2000s and was responsible for building Barratt Homes (or Bang Rui 邦瑞) as it is known in Chinese) into the largest international property developer brand in China with some £1.8 billion of sales to Chinese investors over a eight-year period. James built three large offices and managed 50+ staff in China in multiple times zones.
His understanding of Chinese purchasers and their motivations, particularly of those high net worth individuals is arguably unsurpassed. His teams have created unique social media and branding campaigns that have driven sales and brand awareness across the Mainland.
He believes he has assembled a team with impeccable healthcare CVs and the experience required to nurture and build these demanding clients in the future.
Key Team Members
James M. R. Piesse
Harley+ CEO
- A qualified commercial lawyer turned publisher, author, entrepreneur, China branding and marketing expert with exceptional connections with China's elite and its wealthiest individuals.
- James has been written about widely in the Chinese press and appeared on multiple occasions as a speaker and commentator at events throughout China and on Chinese television and radio.
Elizabeth Boultbee
Harley+ Medical Director of UK Operations
- Highly experienced medical professional overseeing clinical excellence and patient care in the UK.
- Expertise in establishing and maintaining high standards of medical service delivery.
- Strong leadership in healthcare strategy and operational efficiency within the British health sector.
Jessica Morrissey
Harley+ Medical Director of China Operations
- Extensive experience in healthcare management and operations within the Chinese market.
- Specializes in developing and implementing medical protocols tailored for international clients in China.
- Proven track record in building and leading high-performing medical teams.
18
Calvin (Bo) Lee
Harley+ UK-China Medical Liaison Director
- A qualified Chinese orthopaedic surgeon with a Hong Kong MBA.
- Calvin has worked in China's most famous hospitals and the worlds' largest medical equipment providers.
- His marketing and sales experience includes spells as senior product manager at Johnson & Johnson, MedTech (Shanghai) Ltd, Siemens and Medtronic.
Amanda Wong
Harley+ APAC Director of Women’s Health & Longevity
Dr. Amanda Powell qualified as a doctor in 2005 and gained her surgical membership from the Royal College of Surgeons in 2009. She specialised in Orthopaedics, Plastics and Aesthetic Surgery and Medicine before setting up a global wellness clinic partnership chain in Singapore, Marbella, San Diego, Prague, Milan and London. She has also recently completed her MBA with London School of Economics and Political Science (LSE).
Bai Xue
Harley+ Chief China Partnerships Officer
- Bai Xue did his BA and MA at China's finest university Tsinghua and qualified as a senior architect.
- A visiting scholar at Cambridge University.
- His local and Chinese government contacts and relationships are unsurpassed.
- His role is to build bridges with China's top hospitals and health professionals at local and national levels.
19